Blog
RSS FeedPosted by Michael Wonder on 08 Jan 2017
Agenda for 11 January 2017 TC meeting
6 January 2017 - HAS has posted the agenda for the first Transparency Commission meeting for 2017. ...
Posted by Michael Wonder on 07 Jan 2017
Ottawa vows prudent health spending as federal report projects decades of deficits
5 January 2017 - The federal cupboard is bare as Finance Minister Bill Morneau prepares the Liberal government’s second budget ...
Posted by Michael Wonder on 06 Jan 2017
Trastuzumab emtansine and cost-based decision making
7 January 2017 - On 29 December 2016, the NICE in the UK invited comments on their draft guidance for use ...
Posted by Michael Wonder on 06 Jan 2017
German IQWiG confirms additional benefit for Kisplyx (lenvatinib mesylate) in combination with everolimus for the treatment of advanced renal cell carcinoma
4 January 2017 - Approximately 15,000 people in Germany develop renal cell carcinoma every year. ...
Posted by Michael Wonder on 05 Jan 2017
NICE publishes second appraisal consultation for certolizumab pegol and secukinumab
5 January 2017 - NICE is appraising certolizumab pegol and secukinumab for psoriatic arthritis. ...
Posted by Michael Wonder on 05 Jan 2017
Dying mum begs NHS to keep cancer drug free so she can live to see son go to school
5 January 2017 - Dying Bonnie Fox, 39, was diagnosed with secondary cancer in July 2015 only four months after her ...
Posted by Michael Wonder on 05 Jan 2017
Health insurers’ warning: don’t drive young people away
5 January 2017 - Health insurers have warned that the government’s plan to simplify policies through its “gold, silver, bronze” ...
Posted by Michael Wonder on 05 Jan 2017
Pharmacies are a true partnership with the public
5 January 2017 - Terry Barnes' broadside against community pharmacies and the Pharmacy Guild (The Australian Financial Review, January 5) ...
Posted by Michael Wonder on 04 Jan 2017
Provinces seek end to health-funding standoff with Ottawa
3 January 2017 - Finance and health ministers in the provinces and territories that have refused the federal government’s offer ...
Posted by Michael Wonder on 03 Jan 2017
2016 in review
4 January 2017 - The PBAC considered 192 submissions in 2016; 193 were considered by the Committee in 2015. ...
Posted by Michael Wonder on 03 Jan 2017
Amicus Therapeutics set for share of Fabry market after NICE approval
3 January 2017 - England and Wales’ cost effectiveness watchdog NICE has given a final recommendation to a new treatment ...
Posted by Michael Wonder on 03 Jan 2017
The NICE year in review
3 January 2017 - NICE has reflected on some of the news over the past twelve months. ...
Posted by Michael Wonder on 03 Jan 2017
'Morally bankrupt': Government stalls funding for life-saving cystic fibrosis drug for children
3 January 2017 - Little Anna dances around her room, stealing hearts with playful pouts that break into cheeky grins. ...
Posted by Michael Wonder on 03 Jan 2017
NICE says liver cancer treatment to stay within the Cancer Drugs Fund, but not recommended for routine NHS use
30 December 2016 - The drug, sorafenib tosylate (Nexavar), which is used for treating advanced hepatocellular carcinoma, is not value for ...
Posted by Michael Wonder on 02 Jan 2017
Coalition to simplify private health policies
2 January 2016 - The Turnbull government will consider a plan to streamline thousands of private health insurance policies into ...